REGN has been in the news 1200% more than usual
Apr 29, 2025, 6:31 PM
4.28%
What does REGN do
Regeneron Pharmaceuticals, headquartered in Tarrytown, New York, focuses on developing medicines for serious diseases, employing 13,450 people. Its key products include EYLEA, Dupixent, and Libtayo, utilizing advanced technologies like VelociSuite.
REGN has been in the news recently: U.S. stock futures rose, with Dow futures increasing by about 100 points on Tuesday, while Wall Street experienced modest gains as investors looked ahead to important economic data and earnings. Separately, Spotify's stock fell by 5% after reporting first-quarter operating income of 509 million euros, which was below the expected 519.9 million euros.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.